Insight Molecular Diagnostics (IMDX) Deferred Taxes (2020 - 2021)
Insight Molecular Diagnostics' (IMDX) quarterly Deferred Taxes came in at $97000.0 in Q4 2021, up 161.01% year-on-year from $37163.9 in Q4 2020, and up 105.41% quarter-over-quarter from -$1.8 million in Q2 2021.
Insight Molecular Diagnostics (IMDX) Deferred Taxes (2020 - 2021) Analysis & Trends
Insight Molecular Diagnostics has disclosed Deferred Taxes across 2 years of filings, most recently posting $97000.0 for Q4 2021.
- Deferred Taxes for Q4 2021 came in at $97000.0, up 161.01% year-over-year; the trailing twelve-month figure through Dec 2021 was -$9.3 million (down 638.52% YoY), and the FY2021 annual result was -$9.3 million, down 638.52% from the prior year.
- Deferred Taxes came in at $97000.0 for Q4 2021 at Insight Molecular Diagnostics, up from -$1.8 million in the prior quarter.
- In the past five years, Deferred Taxes ranged from a high of $97000.0 in Q4 2021 to a low of -$7.6 million in Q1 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 30,529.42 Bn | 30,528.96 Bn | 1.11 Bn | -1.00 Mn |
| 2 | Thermo Fisher Scientific | 183.75 Bn | 180.50 Bn | 7.74 Bn | -258.00 Mn |
| 3 | Danaher | 133.13 Bn | 127.43 Bn | 3.59 Bn | - |
| 4 | Idexx Laboratories | 46.14 Bn | 45.94 Bn | 722.74 Mn | 13.89 Mn |
| 5 | Agilent Technologies | 38.20 Bn | 36.39 Bn | 990.00 Mn | 32.00 Mn |
| 6 | Natera | 31.50 Bn | 30.40 Bn | 696.04 Mn | - |
| 7 | Iqvia Holdings | 31.34 Bn | 29.36 Bn | 1.36 Bn | -38.00 Mn |
| 8 | Illumina | 24.51 Bn | 23.36 Bn | 721.00 Mn | 3.00 Mn |
| 9 | Mettler Toledo International | 23.53 Bn | 23.47 Bn | 555.82 Mn | -1.99 Mn |
| 10 | Insight Molecular Diagnostics | 4.52 Mn | -24.41 Mn | 15,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | 97,000.00 |
| Jun 30, 2021 | -1.79 Mn |
| Mar 31, 2021 | -7.56 Mn |
| Dec 31, 2020 | -159,000.00 |
| Mar 31, 2020 | -1.10 Mn |